Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum

Journal of Neurochemistry

Volumn 102, Issue 3, 2007, Pages 723-730

  Urbanavicius, Jessika ^a   Ferreira, Margot ^a   Costa, Gustavo ^a   Abin Carriquiry, Juan Andrés ^a   Wonnacott, Susan ^b   Dajas, Federico ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^b University of Bath   (United Kingdom)

Author keywords

6 hydroxydopamine; Dopamine; Neuronal plasticity; Nicotine; Striatum; Tyrosine hydroxylase

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; AMINO ACID DECARBOXYLASE; DOPA; DOPAMINE; NICOTINE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; AXONS; CORPUS STRIATUM; DENERVATION; DOPAMINE; DOWN-REGULATION; LEVODOPA; MALE; NERVE DEGENERATION; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 34447313109     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04560.x     Document Type: Article

References (57)

1. Abin-Carriquiry J. A., McGregor-Armas R., Costa G., Urbanavicius J. Dajas F. (2002) Presynaptic involvement in the nicotine prevention of the dopamine loss provoked by 6-OHDA administration in the substantia nigra. Neurotox Res. 4, 133 139.
2. Acheson A. L. Zigmond M. J. (1981) Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons. J. Neurosci. 1, 493 504.
3. Akaike A., Tamura Y., Yokota T., Shimohama S. Kimura J. (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644, 181 187.
4. Beckstead R. M., Domesick V. B. Nauta W. J. (1979) Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191 217.
5. Belluardo N., Blum M., Mudo G., Andbjer B. Fuxe K. (1998) Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat. Neuroscience 83, 723 740.
6. Benwell M. E. Balfour D. J. (1997) Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur. J. Pharmacol. 325, 13 20.
7. Blum M., Wu G., Mudo G., Belluardo N., Andersson K., Agnati L. F. Fuxe K. (1996) Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat. Neuroscience 70, 169 177.
8. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
9. Carr L. A., Rowell P. P., Pierce W. M. Jr. (1989) Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem. Res. 14, 511 515.
10. Chalar C., Richeri A., Viettro L., Chavez-Genaro R., Bianchimano P., Marmol N. M., Crutcher K., Burnstock G., Cowen T. Brauer M. M. (2003) Plasticity in developing rat uterine sensory nerves: the role of NGF and TrkA. Cell Tissue Res. 314, 191 205.
11. Costa G., Abin-Carriquiry J. A. Dajas F. (2001) Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. Brain Res. 888, 336 342.
12. Cowen T. Thrasivoulou C. (1992) A microscopical assay using a densitometric application of image analysis to quantify neurotransmitter dynamics. J. Neurosci. Methods 45, 107 116.
13. Dajas-Bailador F. A. Wonnacott S. (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25, 317 324.
14. Dajas-Bailador F. A., Lima P. A. Wonnacott S. (2000) The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2 +) dependent mechanism. Neuropharmacology 39, 2799 2807.
15. Demarest K. T. Moore K. E. (1979) Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons. J. Neural Transm. 46, 263 277.
16. Dentresangle C., Le Cavorsin M., Savasta M. Leviel V. (2001) Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Brain Res. 893, 178 185.
17. Domesick V. B. (1981) The antomical basis for feedback and feedforward in the striatonigral system, in : Apomorphine and Dopaminomimetics Gessa G.L. Corsini G.U., eds), pp. 27 39. Raven Press, New York.
18. Ericson C., Georgievska B. Lundberg C. (2005) Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. Eur. J. Neurosci. 22, 2755 2764.
19. Ferger B., Spratt C., Earl C. D., Teismann P., Oertel W. H. Kuschinsky K. (1998) Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 358, 351 359.
20. Fossom L. H., Sterling C. Tank A. W. (1991) Activation of tyrosine hydroxylase by nicotine in rat adrenal gland. J. Neurochem. 57, 2070 2077.
21. Fujisawa H. Okuno S. (2005) Regulatory mechanism of tyrosine hydroxylase activity. Biochem. Biophys. Res. Commun. 338, 271 276.
22. Garrido R., Malecki A., Hennig B. Toborek M. (2000) Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurons. Brain Res. 861, 59 68.
23. Goldstein M., Lee K. Y., Lew J. Y., Harada K., Wu J., Haycock J. W., Hokfelt T. Deutch A. Y. (1995) Antibodies to a segment of tyrosine hydroxylase phosphorylated at serine 40. J. Neurochem. 64, 2281 2287.
24. Goodale D. B. Moore K. E. (1976) A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain. Life Sci. 19, 701 706.
25. Gozal E., Shah Z. A., Pequignot J. M., Pequignot J., Sachleben L. R., Czyzyk-Krzeska M. F., Li R. C., Guo S. Z. Gozal D. (2005) Tyrosine hydroxylase expression and activity in the rat brain: differential regulation after long-term intermittent or sustained hypoxia. J. Appl. Physiol. 99, 642 649.
26. Hiremagalur B. Sabban E. L. (1995) Nicotine elicits changes in expression of adrenal catecholamine biosynthetic enzymes, neuropeptide Y and immediate early genes by injection but not continuous administration. Brain Res. Mol. Brain Res. 32, 109 115.
27. Janson A. M. Fuxe K. (1997) Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion. Exp. Neurol. 146, 575 586.
28. Jonnala R. R. Buccafusco J. J. (2001) Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J. Neurosci. Res. 66, 565 572.
29. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S. Kimura J. (1997) Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors. Brain Res. 765, 135 140.
30. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 227, 680 685.
31. Micutkova L., Kiss A., Filipenko M., Rychkova N., Krizanova O., Palkovits M. Kvetnansky R. (2001) Gene expression of catecholamine synthesizing enzymes in A5 cell group and modulation of tyrosine hydroxylase mRNA by immobilization stress. Endocr. Regul. 35, 195 200.
32. Mitchell S. N., Brazell M. P., Joseph M. H., Alavijeh M. S. Gray J. A. (1989) Regionally specific effects of acute and chronic nicotine on rates of catecholamine and 5-hydroxytryptamine synthesis in rat brain. Eur. J. Pharmacol. 167, 311 322.
33. Mitchell S. N., Smith K. M., Joseph M. H. Gray J. A. (1993) Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 56, 989 997.
34. O'Neill M. J., Astles P., Dell C. P., Keenan M., Murray T. K., Lakics V., Visanji N. P. Duty S. (2005) Neuronal nicotinic receptors and neuroprotection: newer ligands may help us understand their role in neurodegeneration. Med. Chem. Rev. 2, 455 471.
35. Osterhout C. A., Sterling C. R., Chikaraishi D. M. Tank A. W. (2005) Induction of tyrosine hydroxylase in the locus coeruleus of transgenic mice in response to stress or nicotine treatment: lack of activation of tyrosine hydroxylase promoter activity. J. Neurochem. 94, 731 741.
36. Pauly J. R., Charriez C. M., Guseva M. V. Scheff S. W. (2004) Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease. Ann. N. Y. Acad. Sci. 1035, 316 334.
37. Paxinos G. Watson C. (1986) The Rat Brain in Stereotaxic Coordinates., 2nd edn. Academic Press, New York
38. Perrin D., Mamet J., Scarna H., Roux J. C., Berod A. Dalmaz Y. (2004) Long-term prenatal hypoxia alters maturation of brain catecholaminergic systems and motor behavior in rats. Synapse 54, 92 101.
39. Picciotto M. R., Caldarone B. J., King S. L. Zachariou V. (2000) Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22, 451 465.
40. Prieto M., Gomez F. M. Teresa Giralt M. (2003) Effects of acute, repeated and chronic variable stress on in vivo tyrosine hydroxylase activity and on alpha(2)-adrenoceptor sensitivity in the rat brain. Stress 6, 281 287.
41. Quik M. (2004) Smoking, nicotine and Parkinson's disease. Trends Neurosci. 27, 561 568.
42. Quik M., Parameswaran N., McCallum S. E., Bordia T., Bao S., McCormak A., Kim A., Tyndale R. F., Langstom W. Di Monte D. A. (2006) Chronic oral nicotine protects against striatal degeneration in MPTP-treated primates. J. Neurochem. 98, 1866 1875.
43. Ryan R. E., Ross S. A., Drago J. Loiacono R. E. (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br. J. Pharmacol. 132, 1650 1656.
44. Sabban E. L. Gueorguiev V. D. (2002) Effects of short-and long-term nicotine treatment on intracellular calcium and tyrosine hydroxylase gene expression. Ann. N. Y. Acad. Sci. 971, 39 44.
45. Schmitt P., Pequignot J., Garcia C., Pujol J. F. Pequignot J. M. (1993) Regional specificity of the long-term regulation of tyrosine hydroxylase in some catecholaminergic rat brainstem areas. I. Influence of long-term hypoxia. Brain Res. 611, 53 60.
46. Sherman T. G. Moody C. A. (1995) Alterations in tyrosine hydroxylase expression following partial lesions of the nigrostriatal bundle. Brain Res. Mol. Brain Res. 29, 285 296.
47. Singer S., Rossi S., Verzosa S., Hashim A., Lonow R., Cooper T., Sershen H. Lajtha A. (2004) Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function. Neurochem. Res. 29, 1779 1792.
48. Smith K. M., Mitchell S. N. Joseph M. H. (1991) Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J. Neurochem. 57, 1750 1756.
49. Soulage C., Perrin D., Cottet-Emard J. M., Pequignot J., Dalmaz Y. Pequignot J. M. (2004) Central and peripheral changes in catecholamine biosynthesis and turnover in rats after a short period of ozone exposure. Neurochem. Int. 45, 979 986.
50. Sun B., Sterling C. R. Tank A. W. (2003) Chronic nicotine treatment leads to sustained stimulation of tyrosine hydroxylase gene transcription rate in rat adrenal medulla. J. Pharmacol. Exp. Ther. 304, 575 588.
51. Sun B., Chen X., Xu L., Sterling C. Tank A. W. (2004) Chronic nicotine treatment leads to induction of tyrosine hydroxylase in locus ceruleus neurons: the role of transcriptional activation. Mol. Pharmacol. 66, 1011 1021.
52. Treseder S. A., Rose S., Summo L. Jenner P. (2003) Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat. J. Neural Transm. 110, 229 238.
53. Visanji N. P., O'neill M. G. Duty S. (2006) Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle. Neuropharmacol. 3, 506 516.
54. Yamashita H. Nakamura S. (1996) Nicotine rescues PC12 cells from death induced by nerve growth factor deprivation. Neurosci. Lett. 213, 145 147.
55. Yoshimura R., Xu L., Sun B. Tank A. W. (2004) Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medulla. Brain Res. Mol. Brain Res. 126, 188 197.
56. Zanardi A., Leo G., Biagini G. Zoli M. (2002) Nicotine and neurodegeneration in ageing. Toxicol. Lett. 127, 207 215.
57. Zigmond R. E., Schwarzschild M. A. Rittenhouse A. R. (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 12, 415 461.